City

Harrow (1)

Condition

Multiple Sclerosis Healthy Subjects (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Sanofi (1)

Collaborator

Intervention

ripk1 inhibitor (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

multiple sclerosis healthy subjects

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Multiple Sclerosis Healthy Subjects Trial in Harrow (RIPK1 inhibitor)

Completed

Multiple Sclerosis Healthy Subjects

RIPK1 inhibitor

Harrow, London, City Of, United Kingdom

Investigational Site Number :8260001

Apr 21, 2022